Results 191 to 200 of about 86,752 (290)

Different Polymorphisms of the Renin-Angiotensin-Aldosterone System Genes are Associated with Poorer Blood Pressure Control in Hypertensive Older Adults. [PDF]

High Blood Press Cardiovasc Prev
Freire IV, Ribeiro IJS, Casotti CA, Andrade D, Bezerra DD, Teixeira JRB, Barbosa AAL, Campos LCG, Pereira R.   +8 more
europepmc   +1 more source

Automatization of serum thyroxine determination and of T3-uptake test [PDF]

, 1972
Habermann, J., Henner, J., Horn, K., Horst, I. zur, Scriba, Peter Christian   +4 more
core   +1 more source

Effect of inhibitors of the renin angiotensin aldosterone system on markers of oxidative stress, antioxidant enzymes and apoptosis in the common carotid artery of rats induced in the 2K1C hypertension model

Carolina da Silva Valentim
openalex   +1 more source

Risk of acute pancreatitis with DPP‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3033-3043, April 2026.
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki, Akira Okada, Yuya Kimura, Hideo Yasunaga   +3 more
wiley   +1 more source

Impact of Renin-Angiotensin-Aldosterone System Modulation on Cognitive and Neuropsychiatric Outcomes: A Systematic Review of Clinical and Mechanistic Evidence. [PDF]

Cureus
Subhani MK, Sabani A, Omer O, Kheirelsid F, Srour AK.   +4 more
europepmc   +1 more source

Role of the Renin-Angiotensin-Aldosterone System in Dystrophin-Deficient Cardiomyopathy

, 2020
Moisés Rodríguez‐González, Manuel Lubián-Gutiérrez, Helena María Cascales-Poyatos, Álvaro Antonio Pérez-Reviriego, Ana Castellano‐Martínez   +4 more
openalex   +2 more sources

Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3254-3263, April 2026.
Abstract Aims Sotagliflozin, an inhibitor of sodium‐glucose co‐transporter (SGLT)‐1 and 2, reduces albuminuria, slows GFR decline, and may have diuretic and osmoregulatory effects. The effect of sotagliflozin added to insulin was assessed on markers of neurohormone activation and volume homeostasis in patients with type 1 diabetes (T1D).
Massimo Nardone, Erik Moedt, Hiddo J. L. Heerspink, Michael J. Davies, Manon Girard, David Z. I. Cherney, Marcel H. A. Muskiet   +6 more
wiley   +1 more source

Impact of Renin-Angiotensin-Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review. [PDF]

Int J Hypertens
Adhikari A, Sharma C, Lhamu Sherpa M, Karaunakran G, Dhakal M, Sharma A.   +5 more
europepmc   +1 more source

Exploring heart rate variability as a biomarker for frailty: A narrative review

European Journal of Clinical Investigation, Volume 56, Issue 4, April 2026.
Frailty arises from progressive multisystem dysregulation, prompting interest in biomarkers that capture declining physiological reserve. This review positions heart rate variability (HRV) within this evolving biomarker landscape, outlining its physiological basis, analytical domains and relevance to clinical research.
Luca Tagliafico, Silvia Ottaviani, Riccardo Balzano, Stefania Peruzzo, Alessio Nencioni, Fiammetta Monacelli   +5 more
wiley   +1 more source

Updates on the Renin-Angiotensin-Aldosterone System and the Cardiovascular Continuum. [PDF]

Biomedicines
Pop D, Dădârlat-Pop A, Tomoaia R, Zdrenghea D, Caloian B.   +4 more
europepmc   +1 more source